Differential DNA Methylation Patterns in the Prefrontal Cortex and Peripheral Blood Following Antenatal Exposure to Betamethasone
Year: 2024
Type: dissertation
Abstract: Prenatal development is a process that is regulated by various hormones including glucocorticoids. In late gestation, an endogenous glucocorticoid surge promotes fetal lung maturation in preparation for ex utero survival. However, as infants born preterm are born prior to this surge, antenatal corticosteroid (ACS) treatment is administered to pregnant patients at risk of preterm delivery to accelerate fetal lung maturation. While ACS treatment delivers acute benefit and significantly improves rates of neonatal survival in cases of prematurity, exposure to treatment increases risk of neurodevelopmental disorders, particularly among infants born at term. Due to clinical challenges in accurate prediction of preterm birth, approximately 35-40% of pregnancies carry to term following ACS treatment. Despite growing evidence of adverse outcomes following antenatal sGC exposure, the molecular mechanisms that mediate this relationship remain largely unknown. In this project, differential DNA methylation patterns were examined in newborn guinea pig offspring following exposure to antenatal betamethasone. It was identified that antenatal betamethasone exposure targets genes that are involved in regulation of cytoskeletal organization in both prefrontal cortex (PFC) and whole blood. Comparable findings were consistently observed in the juvenile guinea pig PFC, indicating the long-lasting effect of antenatal exposure to sGCs. Furthermore, a unique methylation signature was identified at transcription factor binding sites for PLAGL1, TFAP2C, EGR1, SP1, and ZNF263 in all tissue types examined, highlighting a glucocorticoid-sensitive biomarker that is present in both the blood and the brain. Remarkably, this same methylation signature was also observed in the peripheral whole blood of human neonates following exposure to a single-course of ACS treatment, indicating the possibility to translate our molecular data to a relevant clinical setting. Future studies that build on the current data to examine whether this signature predisposes the development of aberrant neurobehavioural outcomes will be instrumental to our understanding of the mechanistic pathways that result in the development of poor phenotypes following prenatal adversities.
Source: TSpace (University of Toronto)
Author: Kim, Bona
Institution: University of Toronto
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G77807956
OpenAlex ID: W7225769357
